Colorectal cancer is one of the most common cancers in the world. Protein phosphatase magnesium-dependent 1 d (PPM1D) is aberrantly upregulated in many human carcinoma cells, and recent research has suggested that it could be a potential therapeutic target of cancer. However, the function of PPM1D in colorectal carcinoma cells is not well studied. To investigate the function of PPM1D in colorectal carcinoma, we used lentivirus-based RNA silencing to knock down the expression of PPM1D in RKO cells. We found that the lentivirusmediated RNAi system efficiently decreased the expression level of endogenous PPM1D.
Introduction
Colorectal cancer is one of the most common cancers in the world. Many therapeutic methods have been clinically used and have significantly prolonged the life of patients. However, the 5-year survival for colorectal cancer is less than 60% in Europe and 30% in the developed world (1) (2) (3) . New therapeutic methods are urgently needed. RNA interference (RNAi) is a widely used technology to reduce the expression level of target proteins. However, one of the major barriers to realizing the full medicinal potential of RNAi is the difficulty of delivering it in vivo (4) . Lentiviruses are a desirable gene therapy vector and can efficiently deliver RNAi into target cells. Several lentivirus-based gene therapy trials have been approved for clinical usage since 2002 (5) (6) (7) .
Protein phosphatase magnesium-dependent 1 d (PPM1D), also known as wild-type p53-induced serine/threonine phosphatase 1 (Wip1), is required for the relief of p53-dependent checkpoint-mediated cell cycle arrest (8, 9) can lead to a reduction in S phase and G2/M DNA damage checkpoints, while PPM1D knockdown induces more robust intra-S phase and G2/M checkpoints in osteosarcoma U2OS cells (10) . PPM1D is aberrantly upregulated in many human tumors (11) (12) (13) (14) (15) (16) (17) . PPM1D overexpression in vivo accelerated tumor formation after the injection of mouse embryo fibroblasts expressing E1A 1 Ras into nude mice (11) , while PPM1D-deficient mice were resistant to common cancer genes (18) . Further research showed that PPM1D knockdown selectively reduced the growth of human tumor cells (16) . This evidence suggests that PPM1D is a potential therapeutic target of cancer cells.
To investigate the function of PPM1D in colorectal carcinoma, we used lentivirus-based RNA silencing to knock down the expression of PPM1D in RKO cells. We found that the lentivirus-mediated RNAi system efficiently decreased the expression level of endogenous PPM1D. Moreover, inhibiting the activity of PPM1D efficiently inhibited the proliferation and colony formation of RKO cells. Furthermore, we also found that decreased PPM1D expression was accompanied by decreased cyclinB1 expression, reduced ERK phosphorylation and increased AKT phosphorylation. Thus, our results suggest that the lentivirus-mediated RNA silencing system could be an efficient therapeutic method for the treatment of colorectal carcinoma.
Materials and Methods

Cell Cultures
Human colon carcinoma RKO cells and HEK 293T cells were obtained from the Cell Bank of Chinese Academy of Science (Shanghai, China). RKO cells were cultured in 1640 medium (Hyclone) containing 10% (vol/vol) FBS (Gibco). HEK 293T cells were cultured in DMEM (Hyclone) supplemented with 10% (vol/vol) FBS. Cell lines were cultured in the incubator at 378C with 5% CO 2 .
Construction of siRNA-expressing Plasmids
A short hairpin RNA against human PPM1D (NM_003620) was designed (5-CCCTTCTCGTGTTTGCTTAAA-3) and cloned into the vector pFH-L (Shanghai Hollybio, China). A random non-targeting oligo was ligated into the same vector as a negative control.
Lentivirus Packaging and Transfection
293T cells were transfected with shPPM1D or a control short hairpin RNA expression plasmid (shCon) together with two helper plasmids coding for lentivirus-packaging proteins, pCMV∆R8.92 and pVSVG-I (Shanghai Hollybio, China). Forty-eight hours after transfection with Lipofectamine2000 (Invitrogen), culture media containing packaged lentivirus were collected and concentrated using 0.45 mm filters. After the virus titer was determined and calibrated, the lentivirus solution was stored at 2808C. For lentiviral infection, the packaged lentivirus was added to RKO cells and cultured at 378C in 5% CO 2 for at least 3 days.
RNA Extraction and Real-time RT-PCR
After transfection, RKO cells were harvested, and RNA was extracted using Trizol (Invitrogen) according to the manufacturer's instructions. cDNA was then reverse transcribed using M-MLV reverse transcriptase (Promega). The PPM1D expression level was evaluated with real-time polymerase chain reaction (RT-PCR) with the SYBR master mixture (Takara) using a TB800 (Takara). The PPM1D primers were 5-CTACACCACCAGTCAAGTCAC-3 (forward) and 5-AGAAGGCATTGCTACGAACC-3 (reverse). The experiment was repeated at least three times.
Western Blotting
After washing with phosphate-buffered saline (PBS), RKO cells were harvested and lysed with RIPA buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na 3 VO 4 , and 1 mg/ml leupeptin). Protein samples were then separated by SDS-PAGE, transferred, and incubated with primary antibodies overnight at 48C. After incubation with secondary antibodies for 1 hour at room temperature, samples were visualized with enhanced chemiluminescence (Amersham). Primary antibodies against PPM1D (1:1000, Abcam), phosphor-ERK (1:1000, Signalway Antibody), ERK2 (1:1000, Santa Cruz), phosphor-AKT (1:1000, Cell Signaling), AKT (1:500, Cell Signaling), cyclinB1 (1:1000, MBL International), cyclinD1 (1:1000, MBL International), and GAPDH (1:3000, Santa Cruz) were used. Each experiment was performed at least three times.
MTT Cell Proliferation Assay
After lentivirus infection for 3 days, an RKO cell suspension was seeded into a 96-well plate at an initial density of 2000 cells/well. Then, 20 ml 5 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) was added to each well. After the cells were incubated for 3 hours, 100 ml of acidified isopropanol (in 0.01 M HCl) was added to each well. After the formazan precipitate was dissolved, the plates were read in a microplate reader at a wavelength of 595 nm. The experiment was repeated at least three times.
Cell Colony Formation Assay
After lentivirus infection for 3 days, an RKO cell suspension was added to 6-well plates at an initial density of 1200 expression could inhibit colorectal carcinoma cell proliferation and tumor growth. To knock down PPM1D, RKO cells were transfected with lentivirus expressing a short hairpin RNA against PPM1D (Lv-shPPM1D). Lentivirus expressing a control short hairpin RNA (Lv-shCon) was used as a negative control. The lentivirus transfection rate was high and comparable between the Lv-shCon and Lv-shPPM1D groups, as assessed with GFP florescence ( Figure 1A ). We measured the mRNA level of PPM1D with RT-PCR. After transfection with Lv-shPPM1D, the PPM1D expression level was reduced by approximately 60% compared with the noninfected cells and cells infected with Lv-shCon ( Figure 1B) . Then, the protein level was measured using Western blotting. Lv-shPPM1D significantly reduced the endogenous PPM1D protein level ( Figure 1C ).
PPM1D Knockdown Significantly Inhibits the Proliferation and Colony Formation of RKO Cells
To investigate the effects of PPM1D silencing in colorectal carcinoma cells, proliferation and colony formation assays were performed. After Lv-shPPM1D infection, the proliferation rate was decreased compared with non-infected and Lv-shCon-infected cells (Figure 2A) . The colony formation ability of RKO cells was also analyzed. As shown in Figures 2B and 2C , PPM1D silencing significantly reduced the colony formation of RKO cells. Using Giemsa staining, we found that the cell number was greatly reduced in single clones ( Figure 2D ). These results indicate that reducing the endogenous PPM1D expression level significantly inhibited colorectal carcinoma growth. cells/well. Images were acquired when most single clones contained more than 50 cells. Then, samples were fixed using 4% paraformaldehyde, Giemsa staining was performed according to the instructions, and images were acquired All studies were performed at least three times.
Cell Cycle Analysis
After lentivirus infection, RKO cells were collected, resuspended in cold PBS and fixed with pre-chilled 75% ethanol for 30 minutes at 48C. After washing with PBS, the cells were incubated at 48C overnight in the dark with PBS containing RNAase and propidium iodide (PI). The samples were then analyzed with flow cytometry (Cell Lab Quanta, Beckman Coulter), and the data were analyzed using Multi-Cycle AV software (Phoenix Flow Systems, San Diego, CA).
Statistical Analysis
The data were evaluated with Student's t-test, and differences were considered statistically significant at P , 0.05. The results are shown as the mean 6 S.E.M.
Results
Lv-shPPM1D Significantly Reduces Endogenous PPM1D Expression in Colorectal Carcinoma RKO Cells
PPM1D is aberrantly highly expressed in many tumor cells, which leads to the hypothesis that inhibiting PPM1D 
PPM1D Silencing Induces G0/G1 Cell-cycle Arrest in RKO Cells
To investigate whether the PPM1D knockdown-induced cell growth inhibition was caused by cell-cycle dysregulation, flow cytometry analysis was performed. As shown in Figures  3A and 3B , Lv-shPPM1D infection induced an accumulation of RKO cells in the G0/G1 phase of the cell cycle. In the Lv-shPPM1D-infected group, 45.87 6 0.64% of RKO cells were in the G0/G1 phase of the cell cycle, which was significantly higher than the non-infected group (38.67 6 0.93%) and Lv-shCon-infected group (42.60 6 0.95%). In the PPM1D-silenced group, 44.00% 6 0.17% of RKO cells were in the S phase of the cell cycle, which was much lower than the non-infected group (52.20 6 0.62%) and the Lv-shCon-infected group (48.50 6 1.25%) ( Figures  3A & 3B) . We further analyzed the percentage of cells in sub-G1 phase. After PPM1D knockdown, 5.98 6 0.35% of cells were in the sub-G1 phase, which was much higher than the non-infected group (1.47 6 0.11%) and Lv-shCon group (1.70 6 0.08%) ( Figure 3C) . These results suggest that PPM1D knockdown induces cell accumulation in the sub-G1 phase, leading to the inhibition of cell proliferation and colony formation.
Effects of PPM1D Silencing on Cell Growth-related Signaling Molecules
To further investigate the mechanisms of PPM1D silencing-induced carcinoma cell growth inhibition, we analyzed the expression levels of cell growth-related signaling molecules. CyclinB1 and cyclinD1 are regulatory proteins involved in cell-cycle control (19) (20) (21) . We found that PPM1D knockdown led to the downregulation of cyclinB1 but did not influence cyclinD1 expression (Figure 4 ). Because the ERK signaling pathway plays an important role in cell proliferation (22, 23) and PPM1D is dependent on ERK activation, we evaluated ERK activation after PPM1D knockdown. We found that inhibiting PPM1D expression in colorectal carcinoma cells led to a reduction in the amount of phosphorylated ERK. Furthermore, we measured AKT pathway activation, as phosphor-AKT is also related to cell proliferation (23, 24) . We found that after PPM1D knockdown with Lv-shPPM1D, the amount of phosphor-AKT was dramatically increased (Figure 4) . The above evidence indicates that inhibiting PPM1D expression through lentivirus-mediated RNA silencing inhibited colorectal carcinoma cell proliferation through suppressing the cyclinB1/ERK pathway. 
Discussion
Colorectal cancer is one of the most common cancers in the world. Although survival can be significantly extended by surgery, chemotherapy, and radiation, half of colorectal patients die within 5 years (1) . New therapeutic methods are urgently needed. RNAi is a widely used technology to silence target genes through reducing the mRNA level. However, one of the major barriers to realizing the full medicinal potential of RNAi is the difficulty of delivering it in vivo (4) . Lentivirus can efficiently deliver RNAi into target cells, and since 2002, several lentivirus-based gene therapy trials have been approved for clinical usage (5, 25) . Thus, lentivirusmediated RNAi is a promising gene therapeutic method to cure colorectal cancer in the clinic.
PPM1D is a serine/threonine phosphatase that is aberrantly overexpressed in many different cancer types (11) (12) (13) (14) (15) (16) (17) . Inhibiting its activity using specific compounds could selectively reduce the viability of human tumor cell lines that overexpress PPM1D (16) . Knocking down PPM1D expression inhibits the proliferation and invasion of human glioma cells and breast carcinoma cells (26, 27) . These results show that PPM1D is a promising therapeutic target. Here, we used lentivirus-based RNAi technology to specifically inhibit PPM1D expression in human colorectal carcinoma cells. We found that cell proliferation and colony formation were significantly inhibited by PPM1D silencing. Thus, our research suggests that the lentivirus-mediated delivery of PPM1D RNAi is a potential therapeutic method to treat colorectal cancer in the clinic. In our research, we showed that Lv-shPPM1D efficiently reduced endogenous PPM1D expression and led to the inhibition of cell proliferation and colony formation of colorectal RKO cells. Further experiments showed that PPM1D knockdown led to cell-cycle arrest at the G0/G1 phase and cell accumulation at the sub-G1 cell-cycle phase, which led to cell growth inhibition. To further explore the detailed mechanisms of cell-cycle arrest and cell proliferation inhibition, we measured the expression levels of some cell cycle-related molecules. We found that PPM1D knockdown induced the downregulation of cyclinB1 and phosphor-ERK but did not influence cyclinD1 expression. Interestingly, we also found that PPM1D knockdown promoted AKT phosphorylation, which indicates that the PI3K/AKT pathway is activated. Thus, cyclinB1, ERK and AKT might be downstream signaling molecules of PPM1D. The PPM1D knockdown-induced downregulation of cyclinB1, phosphor-ERK and AKT activation might be the molecular mechanisms that lead to cell-cycle arrest and cell proliferation inhibition in RKO cells.
In conclusion, we found that PPM1D plays a crucial role in colorectal carcinoma cell proliferation and colony formation. Our work provides strong evidence suggesting that PPM1D is a potential therapeutic target in human colorectal cancers. Lentivirus-mediated PPM1D silencing is a promising gene therapeutic method to treat colorectal cancers.
